Eli Lilly & Co. is the latest big pharma to unveil a major artificial intelligence (AI) drug discovery collaboration after signing an agreement with one of the pioneers in the field, San Francisco-based Atomwise Inc..
The companies will collaborate on up to 10 drug targets selected by Lilly, with the goal of accelerating the time...